White Widow
The 1990s Dutch hybrid that helped define modern cannabis branding, with a lineage story that's never been fully settled.
White Widow is a real piece of cannabis history — a 1990s Dutch coffeeshop staple that helped popularize the 'frosty white trichome' aesthetic. But most 'White Widow' sold today shares little more than a name with the original. The lineage is genuinely disputed, the chemistry varies wildly between seed banks, and the classic 'balanced hybrid' descriptors are marketing more than measurement. It's a fine strain. It is not a stable, consistent product across the market.
Overview
White Widow emerged from the Dutch coffeeshop scene in the mid-1990s and won the High Times Cannabis Cup in 1995 [1]. Its trichome-heavy buds — so resinous they appear dusted in white — became a defining visual of the era and arguably set the template for the 'frosty' aesthetic that still drives strain marketing today.
It remains one of the most-searched and most-sold strain names in the world. Whether the plant you buy under that name has any genetic relationship to the 1990s original is a different question entirely. Because cannabis genetics were not formally protected and seed lines were widely copied, 'White Widow' today functions more like a brand than a cultivar.
Chemistry
Reported cannabinoid content for modern White Widow lines ranges from roughly 18% to 25% THC, with negligible CBD (<1%) Weak / limited. These figures come from seed-bank self-reports and dispensary lab data, which are not standardized and frequently inflated [2].
Terpene profiles vary by phenotype and grower. Myrcene is most commonly reported as dominant, often followed by pinene and caryophyllene Weak / limited. Some cuts lean terpinolene-forward. There is no single 'true' White Widow terpene signature in published data — what you'll see on a COA depends on which seed line and which grow.
A note on folklore: the widely cited '0.5% myrcene threshold' that supposedly separates 'indica' from 'sativa' effects has no basis in peer-reviewed pharmacology No data. Treat any vendor claim hinging on it skeptically.
Reported effects
Consumers commonly describe White Widow as producing a clear-headed, talkative, energetic high with mild body relaxation — the prototypical 'balanced hybrid' description Anecdote. These reports come from forums, dispensary menus, and review aggregators, not controlled studies.
There are no strain-specific clinical trials of White Widow. Cannabis research generally studies isolated cannabinoids (THC, CBD) or whole-plant extracts standardized to those compounds — not named cultivars [3]. Any claim that White Widow specifically treats a condition is unsupported No data.
The broader 'indica vs sativa predicts effects' framework that underlies most strain effect descriptions has been directly challenged in the scientific literature. Chemical analyses show the indica/sativa labels do not reliably map to chemotype or reported effects [4] Strong evidence. In practice, expect effects to vary by your dose, tolerance, the specific phenotype, and how it was grown and cured.
Lineage (disputed)
The standard story is that White Widow is a cross of a Brazilian sativa landrace and a South Indian indica hybrid, brought to the Netherlands and stabilized in the early 1990s [1].
Who actually bred it is genuinely contested. Two principal claims:
- Green House Seeds (Arjan Roskam) markets White Widow as one of their flagship strains and lists it among their Cannabis Cup wins [1].
- Shantibaba (Scott Blakey), co-founder of Mr. Nice Seedbank and formerly of Green House, says he bred the original line before leaving Green House and that his version — sometimes sold as 'Black Widow' at Mr. Nice — is the true original [5] Disputed.
Without independent genetic provenance records from the early 1990s, this dispute cannot be resolved from public sources. Modern genomic studies of cannabis cultivars have shown that strains sharing a name frequently differ genetically, and strains with different names frequently don't [6] Strong evidence. 'White Widow' from two different banks may not be the same plant in any meaningful sense.
Cultivation basics
White Widow has a reputation as a beginner-friendly strain: moderately vigorous, forgiving of mistakes, and finishing in roughly 8–9 weeks of flowering indoors Anecdote. Reported indoor yields cluster around 450–550 g/m² under competent conditions; outdoor harvest in the Northern Hemisphere is typically late October.
Structure is usually medium-height with strong lateral branching, responding well to topping and low-stress training. Heavy trichome production is the defining trait — and the source of the name. Growers commonly report it handles a range of substrates (soil, coco, hydro) without major issues.
Because 'White Widow' is sold by many seed banks with no shared standard, expect substantial variation between sources in vigor, flowering time, and yield. Reviews of one bank's White Widow do not generalize to another's.
Marketing vs. reality
What's real:
- White Widow is a legitimate piece of cannabis history with documented Cup wins in the mid-1990s [1].
- The original line was genuinely notable for trichome production and helped shape consumer expectations of bud appearance.
What's marketing:
- 'The original White Widow' — multiple vendors claim this; the claim cannot be independently verified for most.
- Specific THC percentages on packaging — typically self-reported, frequently inflated, and not comparable across labs [2] Strong evidence.
- 'Balanced hybrid effects' — a descriptor with no pharmacological definition.
- Curative or therapeutic claims tied to the strain name — unsupported by clinical evidence No data.
If you want to try White Widow, do so for the experience and the history. Don't expect a consistent product across brands, and don't pay a premium for the name alone.
Sources
- Reported High Times Magazine. Cannabis Cup winners archive, 1995. High Times. ↗
- Peer-reviewed Jikomes, N., & Zoorob, M. (2018). The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific Reports, 8, 4519.
- Peer-reviewed National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. The National Academies Press.
- Peer-reviewed Watts, S., McElroy, M., Migicovsky, Z., Maassen, H., van Velzen, R., & Myles, S. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7, 1330–1334.
- Reported Danko, D. (2009). 'The Shantibaba Interview.' High Times. Interview with Scott Blakey discussing White Widow's origins and his split from Green House Seeds. ↗
- Peer-reviewed Sawler, J., Stout, J. M., Gardner, K. M., Hudson, D., Vidmar, J., Butler, L., Page, J. E., & Myles, S. (2015). The Genetic Structure of Marijuana and Hemp. PLOS ONE, 10(8), e0133292.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.